Biomarkers from Bench to Bedside: Tools, Targets, and Translational Insights
Explore how new tools and strategies are advancing biomarker discovery, standardization, and translational research in oncology and beyond.
Integrating Functionalized Multi-omics in Oncology Drug Discovery
Discover how cutting-edge multi-omics approaches and Generative AI are reshaping oncology drug discovery.
Leveraging Genomic, Preclinical, and Drug Response Data in the Age of AI
Join Dr. Michael Boice from Certis Oncology for a discussion and demonstration of how artificial intelligence can improve preclinical decision-making in cancer research.
Discovery and Engineering of High-Affinity Soluble T Cell Receptors via a High-Throughput Yeast-Based Platform
Join Dr. Garrett Rappazzo as he presents his team’s research on the discovery and engineering of soluble T cell receptors for peptide-HLA targeting therapeutics.
High-Quality Mobilized Leukopaks to Enhance Your Cell and Gene Therapy Research and Development
Learn about mobilized leukopaks, CD34+ cell isolation, and cutting-edge techniques in cell and gene therapy research with STEMCELL Technologies.
Considerations in Tissue Acquisition and Characterization for the Development of Long-Term Tumoroid Models
Join experts from Discovery Life Science as they explore cutting-edge 3D tumor models and their potential to accelerate cancer research and development.
New Insights into Aging: Which Aging Theory Prevails?
Read about groundbreaking research from UC San Diego linking genetic mutations and epigenetic changes, offering new insights into the molecular mechanisms of aging and reshaping future anti-aging strategies.
The Impact of Nutrition on T Cell Fate and Exhaustion
Researchers at the Salk Institute have discovered that a switch from acetate to citrate as a nutritional source significantly influences T cell identity, particularly transforming active effector T cells into exhausted ones in chronic infections like cancer and HIV.
Fruit Fly Research Unveils Potential Anti-Aging Strategies
This article from GEN discusses the impact that filamentous actin (F-actin) buildup has on the healthy aging of fruit flies.
Arrayed CRISPR screening for phenotypic discovery at the MRC-AstraZeneca-University of Cambridge Joint Functional Genomics Screening Laboratory (FGSL)
The FGSL aims to form collaborations to advance our understanding of development and disease mechanism through functional interrogation of the genome at scale.
Reprogramming the Brain Tumor Microenvironment to Enhance Anti-Tumor Immunity
This Q&A report covers essential topics in reprogramming the brain tumor microenvironment, including macrophage roles, cytokine expression, and approaches to overcoming tumor immunosuppression.
Unraveling Immunotherapy Resistance in Advanced Melanoma: Novel Insights from Longitudinal Spatial Multiomics Studies
Explore immunotherapy resistance in melanoma with Dr. Camelia Quek through advanced spatial multiomics and single-cell analysis insights.
Licensing Biological Materials: Crucial Considerations for Preclinical Researchers
Licensing biological material is critical to the success of preclinical research—join us to gain insights and avoid costly pitfalls.
Reprogramming the Brain Tumor Microenvironment to Enhance Anti-Tumor Immunity
Join us to learn how recent discoveries about the brain tumor microenvironment can drive new therapeutic strategies to overcome tumor immunosuppression.
Talking Real Science with Rachel Buckley
On this episode of #ShareScience, we spoke with Dr. Rachel Buckley, whose research interests lie in sex differences in risk for Alzheimer’s disease.
Talking Real Science with Rachel Buckley
This episode of Share Science features Rachel Buckley, PhD who shares her research on sex differences in Alzheimer's Disease and why she’s passionate about women’s health.
A New Approach to Vector-Free CRISPR Editing Starting From Single Cells
Join us to learn how CellEDIT can be used for targeted gene editing.
Hematopoietic Stem Cell Fitness and Function During Sickle Cell Disease
Join Dr. Shannon McKinney-Freeman as she presents research on the relationships between sickle cell disease, hematopoietic stem cells, and risks of clonal hematopoeisis and leukemia.
Illuminating Immunohistochemistry: From Biomarker to Clinical Trial Assay
Join us for an in-depth exploration of immunohistochemistry (IHC) in the first installment of our comprehensive webinar series with Precision for Medicine.
Implementing the Colony-Forming Unit (CFU) Assay As a Potency Assay for Hematopoietic Cell Therapy Products
Join our webinar to learn how to effectively implement the CFU assay as a potency assay for hematopoietic cell therapy products.
Translational T Cell Talks: Scaling for the Future
Join STEMCELL's Translational T Cell Talks on June 11, 2024 for a half-day event featuring presentations on CAR T cell research, new protocols, educational content, and special promotions.
Circulating Nucleosome Quantification (Nu.Q®) Technology for Monitoring Target Engagement and Adverse Events in Oncology Trials
Join us for a comprehensive webinar featuring experts in epigenetics and assay development, focusing on the scientific foundations and applications of Nucleosome Quantification (Nu.Q®) Technology in the realms of drug development and disease monitoring.
#ExpertAnswers: Jack Vanden Heuvel on Prediction Drug-Drug Interactions Early
Dr. Jack Vanden Heuvel from Penn State University and INDIGO Biosciences answers questions from a recent webinar where he discusses [...]
#ExpertAnswers: Travis Hardcastle and Seth Hanson on Using CRISPR and iPSCs for Neuroscience Research
Travis Hardcastle and Seth Hanson answer questions from a webinar where they discuss innovative applications of CRISPR and iPSCs in disease modeling and drug discovery.
Developing a Novel Gene Therapy for Kcnv2 Retinopathy
Livia Carvalho, PhD discusses her team's successful development of a novel AAV-based gene therapy approach for KCNV2 retinopathy in a Kv8.2 knockout mouse model.
